Detection and Characterization of Diarrheagenic Escherichia coli from Young Children in Hanoi, Vietnam

Diarrhea continues to be one of the most common causes of morbidity and mortality among infants and children in developing countries. Escherichia coli is an emerging agent among pathogens that cause diarrhea. The development of a highly applicable technique for the detection of different categories...

Full description

Saved in:
Bibliographic Details
Published inJournal of Clinical Microbiology Vol. 43; no. 2; pp. 755 - 760
Main Authors Nguyen, Trung Vu, Le Van, Phung, Le Huy, Chinh, Gia, Khanh Nguyen, Weintraub, Andrej
Format Journal Article
LanguageEnglish
Published Washington, DC American Society for Microbiology 01.02.2005
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Diarrhea continues to be one of the most common causes of morbidity and mortality among infants and children in developing countries. Escherichia coli is an emerging agent among pathogens that cause diarrhea. The development of a highly applicable technique for the detection of different categories of diarrheagenic E. coli is important. We have used multiplex PCR by combining eight primer pairs specific for enteroaggregative E. coli (EAEC), enteroinvasive E. coli (EIEC), enterohemorrhagic E. coli, enteropathogenic E. coli (EPEC), and enterotoxigenic E. coli (ETEC). This facilitates the identification of five different categories of diarrheagenic E. coli from stool samples in a single reaction simultaneously. The prevalences of diarrheagenic E. coli were 22.5 and 12% in the diarrhea group and the control group, respectively. Among 587 fecal samples from Vietnamese children under 5 years of age with diarrhea, this technique identified 132 diarrheagenic E. coli strains. This included 68 samples (11.6%) with EAEC, 12 samples (2.0%) with EIEC, 39 samples (6.6%) with EPEC, and 13 samples (2.2%) with ETEC. Among the 249 age-matched controls, 30 samples were positive for diarrheagenic E. coli. The distribution was 18 samples (7.2%) with EAEC, 11 samples (4.4%) with EPEC, and 1 sample (0.4%) with ETEC.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Corresponding author. Mailing address: Department of Laboratory Medicine, Division of Clinical Bacteriology, Karolinska Institutet, F-82 Karolinska University Hospital, Huddinge, S-141 86 Stockholm, Sweden. Phone: 46 8 585 87831. Fax: 46 8 711 3918. E-mail: andrej.weintraub@labmed.ki.se.
ISSN:0095-1137
1098-660X
DOI:10.1128/JCM.43.2.755-760.2005